US-UK Pharma Deal: NHS Costs & Risks
US Deal UK Pharma Market: Expert Warnings on Hidden Risks to NHS Access and Costs Zero Tariffs Boost Exports: UK pharma firms gain tariff-free access…
Newsroom
US Deal UK Pharma Market: Expert Warnings on Hidden Risks to NHS Access and Costs Zero Tariffs Boost Exports: UK pharma firms gain tariff-free access…
Earnings Live: Salesforce Stock Rises on Upbeat Guidance, Snowflake Tumbles, and American Eagle Surges – What Investors Need to Know Salesforce Delivers AI-Powered Wins: The…
Marvell’s Bold $5.5 Billion Move: Acquiring Celestial AI to Supercharge AI Data Centres with Optical Magic Game-Changer for AI Infrastructure: Marvell’s buyout of Celestial AI…
Okta Shares Tumble: Why the Company Declined Guidance for Next Fiscal Year and What It Means for Investors Strong Q3 Beat, But No FY2027 Outlook:…
What to Expect in Markets This Week: Retail Sales Surge, Earnings from Deere, Dell, and Alibaba, and Thanksgiving’s Holiday Boost Key Takeaways Retail Sales Heat…
NICE Cost-Effectiveness Thresholds Increased: How the UK-US Trade Deal is Unlocking Better Access to Life-Saving Drugs Faster Access to Breakthrough Treatments: The new thresholds could…